Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by stockfyon May 06, 2022 4:19am
292 Views
Post# 34661223

VMD: Top line & bottom line YoY growth, Bright Outlook, 5X

VMD: Top line & bottom line YoY growth, Bright Outlook, 5X VMD's Q1 2022 results:

Top line YoY growth, bottom line YoY growth, operating cash flow YoY growth, free cash flow for another quarter in a row, net cash keeps going up and bright outlook:


“The record setting quarter in our core business is a reflection of the momentum we are beginning to see in a post pandemic environment,” said Casey Hoyt, CEO. “Our investments in people, technology and inventory during the pandemic have positioned us extremely well to actively engage with patients, providers, and payors as pandemic restrictions abate. We are invigorated by the increasing opportunities for face-to-face interaction with the people we serve in the coming months.” 


Full article:

https://www.hmenews.com/article/viemed-healthcare-sees-investments-pay-off



With a net cash position of approximately US$24 million, US$190 million Enterprise Value and about US$35 million adj. EBITDA this year (excluding any acquisitions), VMD at US$5.50 per share trades only 5 times its adj. EBITDA.

This is the definition of a bargain. VMD is dirt-cheap both on absolute and relative valuation analysis while being a takeover target for a larger healthcare name.


Do not forget that VMD's indebted peer Apria (APR) was bought out a few weeks ago:

https://www.businesswire.com/news/home/20220329005649/en/Owens-Minor-Inc.-Completes-Acquisition-of-Apria-Inc.



<< Previous
Bullboard Posts
Next >>